US20210268270A1 - Nerve cuff electrode locking mechanism - Google Patents
Nerve cuff electrode locking mechanism Download PDFInfo
- Publication number
- US20210268270A1 US20210268270A1 US17/308,350 US202117308350A US2021268270A1 US 20210268270 A1 US20210268270 A1 US 20210268270A1 US 202117308350 A US202117308350 A US 202117308350A US 2021268270 A1 US2021268270 A1 US 2021268270A1
- Authority
- US
- United States
- Prior art keywords
- strap
- buckle
- nerve
- cuff body
- lead
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000005036 nerve Anatomy 0.000 title claims abstract description 61
- 230000004044 response Effects 0.000 claims abstract description 15
- 239000004020 conductor Substances 0.000 claims abstract description 9
- 230000037303 wrinkles Effects 0.000 abstract description 25
- 208000001797 obstructive sleep apnea Diseases 0.000 description 12
- 210000001169 hypoglossal nerve Anatomy 0.000 description 7
- 238000002513 implantation Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229920002529 medical grade silicone Polymers 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0556—Cuff electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4818—Sleep apnoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0558—Anchoring or fixation means therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/296—Bioelectric electrodes therefor specially adapted for particular uses for electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6877—Nerve
Definitions
- the present invention generally relates to implantable neurostimulation leads, and specifically relates to implantable nerve cuff electrodes that can be used to stimulate nerves to treat ailments, such as obstructive sleep apnea (OSA).
- OSA obstructive sleep apnea
- OSA Obstructive sleep apnea
- apnea obstructed
- hyperpnea partially obstructed
- Conventional treatments of OSA include using continuous positive airway pressure (CPAP) techniques or performing upper airway surgery.
- CPAP continuous positive airway pressure
- CPAP has a low adherence rate over time, thereby limiting its effectiveness.
- upper airway surgery is painful and requires a prolonged recovery period, and therefore is used as a last resort to the treatment of OSA, reserved for only extreme cases.
- one such neurostimulation system for treating OSA includes a neurostimulator device that stimulates one or more branches of the hypoglossal nerve via electrodes that are implanted at the hypoglossal nerve. Further details discussing such a neurostimulation system are described in U.S. Patent Publication No. 2016/0354608, which is expressly incorporated herein by reference.
- any electrode implanted in contact with a nerve such as the hypoglossal nerve, continually remain in firm contact with such nerve to maximize the effectiveness of the stimulation regimen.
- a nerve such as the hypoglossal nerve
- certain regions of the patient such as the neck region, are subject to various dynamic forces that may dislodge or otherwise cause an electrode to migrate from or otherwise temporarily move from its original or desired implantation site, which may have deleterious effect on the stimulation regimen, and thus, the treatment of the ailment, such as OSA.
- a reliable solution to this migration problem is to use a nerve cuff electrode device, which can be circumferentially placed around the nerve to deliver effective electrical stimulation to that nerve.
- This approach provides a more effective anchoring means that keeps the electrode in firm contact with the nerve to which it is attached even when the implantation site is subject to dynamic forces.
- a nerve cuff can be wrapped around the hypoglossal nerve trunk or its branch that innervates the muscle that protrudes the tongue.
- a conventional approach to securing a nerve cuff electrode to a nerve involves placing the cuff, which is generally C-shaped, around the nerve and tightly closing and sealing the cuff by tying sutures at two edges or flaps of the cuff to fully encircle the nerve.
- sutures to secure the nerve cuff electrode has several disadvantages. For example, braided suture material easily attracts and retains contaminants, connective tissue can grow on the sutures making removal of the cuff difficult, and sutures tend to breakdown when exposed to a fluid environment, thereby resulting in failure of the sutures and potentially allowing the cuff to open.
- an electrode lead comprises an elongated lead body, at least one lead connector terminal affixed to the proximal end of the lead body, and a biologically compatible, elastic, electrically insulative cuff body affixed to the distal end of the lead body, and at least one electrical conductor extending through the lead body between the connector terminal(s) and the electrode contact(s).
- the cuff body is configured for being circumferentially disposed around a nerve, and has opposing first and second regions.
- the cuff body may be composed of, e.g., silicone.
- the cuff body may be configured and sized for being placed around on a human hypoglossal nerve trunk or its branch nerve.
- the cuff body may be configured for expanding and accommodating both a normal-sized nerve diameter and then later, after implantation of the electrode lead, an increased nerve diameter due to swelling, thereby preventing nerve constriction due to the nerve swelling.
- the electrode contact(s) is configured for being on an inner surface of the cuff body when secured around the nerve.
- the electrode lead further comprises a strap extending from the first region of the cuff body, and a buckle disposed on the second region of the cuff body.
- the strap may have, e.g., a thickness less than 1 mm.
- the electrode lead comprises at least one raised protuberance (e.g., a button or a dome) disposed on a planar surface of the strap.
- the strap with the raised protuberance(s) is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap, and one of the raised protuberance(s) is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the cuff body around the nerve.
- the one raised protuberance and the strap, in their relaxed state have a combined first height
- the aperture of the buckle, in its relaxed state has a second height less than the first height.
- the first height is less than twice the second height.
- the electrode lead comprises a ring incorporated into the strap.
- the strap with the ring is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap, and the ring is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the cuff body around the nerve.
- the ring in its relaxed state, has a first width
- the aperture of the buckle, in its relaxed state has a second width less than the first width.
- the first width is less than twice the second width.
- the ring, in its relaxed state may be, e.g., circular, oval, or rectangular.
- the electrode lead comprises at least one wrinkle (e.g., a folded region or a curved region) incorporated into the strap.
- the strap with the wrinkle(s) is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap, and one of the wrinkle(s) is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the tightened cuff body around the nerve.
- the one wrinkle, in its relaxed state spans a first height
- the aperture of the buckle, in its relaxed state has a second height less than the first height.
- the first height is less than twice the second height.
- FIG. 1 is a perspective view of an electrode lead constructed in accordance with one embodiment of the present inventions
- FIG. 2 is a plan view of a cuff electrode of the electrode lead of FIG. 1 , which can be rolled up and circumferentially disposed around a nerve;
- FIG. 3 is an end view of the cuff electrode of FIG. 2 ;
- FIG. 4 is a perspective view of the cuff electrode of FIG. 2 , particularly showing a protuberance used in a strap and buckle arrangement for securing the cuff electrode to the nerve;
- FIG. 5 a is a side view of one embodiment of the protuberance of FIG. 4 in the form of a button
- FIG. 5 b is a side view of another embodiment of the protuberance of FIG. 4 in the form of a dome;
- FIGS. 6 a and 6 b are respective top and side views illustrating the protuberance prior to pulling the strap through the buckle;
- FIGS. 7 a and 7 b are respective top and side views illustrating the protuberance pulled into the buckle by pulling the strap;
- FIGS. 8 a and 8 b are respective top and side views illustrating the protuberance pulled out of the buckle by pulling the strap;
- FIGS. 9 a and 9 b are respective top and side views illustrating the protuberance engaging the edge of the buckle in a locked position by releasing tension on the strap;
- FIG. 10 is a perspective view of the cuff electrode of FIG. 2 , particularly showing a ring used in a strap and buckle arrangement for securing the cuff electrode to the nerve;
- FIG. 11 a is a top view of one embodiment of the ring of FIG. 10 in the form of a circular ring;
- FIG. 11 b is a top view of another embodiment of the ring of FIG. 10 in the form of an oval ring;
- FIG. 11 c is a top view of still another embodiment of the ring of FIG. 10 in the form of a rectangular ring;
- FIGS. 12 a and 12 b are respective top and side views illustrating the ring prior to pulling the strap through the buckle;
- FIGS. 13 a and 13 b are respective top and side views illustrating the ring pulled into the buckle by pulling the strap;
- FIGS. 14 a and 14 b are respective top and side views illustrating the ring pulled out of the buckle by pulling the strap;
- FIGS. 15 a and 15 b are respective top and side views illustrating the ring engaging the edge of the buckle in a locked position by releasing tension on the strap;
- FIG. 16 is a perspective view of the cuff electrode of FIG. 2 , particularly showing a wrinkle used in a strap and buckle arrangement for securing the cuff electrode to the nerve;
- FIG. 17 a is a side view of one embodiment of the wrinkle of FIG. 16 in the form of a folded region
- FIG. 17 b is a side view of another embodiment of the wrinkle of FIG. 16 in the form of a curved region;
- FIGS. 18 a and 18 b are respective top and side views illustrating the wrinkle prior to pulling the strap through the buckle;
- FIGS. 19 a and 19 b are respective top and side views illustrating the wrinkle pulled into the buckle by pulling the strap
- FIGS. 20 a and 20 b are respective top and side views illustrating the wrinkle pulled out of the buckle by pulling the strap.
- FIGS. 21 a and 21 b are respective top and side views illustrating the wrinkle engaging the edge of the buckle in a locked position by releasing tension on the strap.
- an electrode lead 10 constructed in accordance with one embodiment of the present invention will now be described.
- the electrode lead 10 lends itself well to be used in the treatment of OSA by stimulating the hypoglossal nerve, the electrode lead 10 may be used for any medical treatment where it is desired to stimulate a nerve.
- the electrode lead 10 generally comprises an elongated lead body 12 having a proximal end 14 and a distal end 16 , at least one lead connector terminal 18 (two shown) affixed to the proximal end 14 of the lead body 12 , a cuff body 20 affixed to the distal end 16 of the lead body 12 , at least one electrode contact 22 (three shown in FIG. 2 ) disposed on the cuff body 20 , and at least one electrical conductor 24 (two shown) extending through the lead body between the lead connector terminals 18 and the electrode contacts 22 .
- the cuff body 20 can be circumferentially disposed around tissue, e.g., a nerve 26 , such that the electrode contacts 22 are disposed on an inner surface of the cuff body 20 in contact with the nerve 26 .
- the electrode contacts 22 may be used to form a guarded tripolar electrode arrangement (e.g., anode-cathode-anode) for purposes of stimulating the nerve 26 .
- a guarded tripolar electrode arrangement e.g., anode-cathode-anode
- Two of the electrode contacts 22 are ganged together and coupled to one of the lead connector terminals 18 via an electrical conductor 24
- the remaining electrode contact 22 (the cathode) is coupled to the other lead connector terminal 18 via the other electrical conductor 24 .
- the number of electrode contacts 22 , lead connector terminals 18 , and electrical conductors 24 can be identical, such that electrode contacts 22 may be energized independently of each other.
- the lead connector terminals 18 of the proximal end 14 of the lead body 12 can be inserted into a connector block 30 of a neurostimulation device 28 , which supplies electrical pulses to one or more of the electrode contacts 22 in accordance with a stimulation regimen.
- Recording electrodes (not shown) can also be connected to the neurostimulation device 28 to provide sensed physiological signals to the neurostimulation device 28 .
- one or more of the electrode contacts 22 of the electrode lead 10 can serve as a recording electrode.
- the lead body 12 and cuff body 20 may be composed of an elastic, electrically insulative, biocompatible, material, such as, e.g., medical-grade silicone, polyurethane, etc.
- the lead connector terminals 18 may be composed of a suitable electrically conductive material, such as, e.g., stainless steel, and the electrode contacts 22 may be composed of a suitable electrically conductive and biocompatible material, such as gold, or 90/10 or 80/20 Platinum-Iridium alloy.
- the electrical conductors 24 may likewise be composed of a suitable electrically conductive and biocompatible material, such as MP35N, MP35N with silver core, stainless steel, or tantalum.
- the cuff body 20 is relatively thin, e.g., and may have a thickness less than 1 mm, and may often be less than 0.5 mm, so that the cuff body 20 may be easily disposed around in conformance with the nerve 26 .
- the cuff body 20 may take the form of a planar sheet (as best shown in FIG. 2 ) that can be rolled up on itself to be circumferentially disposed around the nerve 26 (as best shown in FIG. 1 ).
- the electrode lead 10 includes locking features that allow the cuff body 20 to be secured around the nerve 26 without the use of sutures and in a manner that minimizes the chance that the cuff body 20 can be dislodged from the nerve 26 after implantation of the cuff around the nerve.
- the cuff body 20 may comprise a strap 32 extending from a first region 36 of the cuff body 20 , and a buckle 34 disposed on the surface of a second region 38 of the cuff body 20 .
- the strap 32 and cuff body 20 are unitary in nature and may be formed of the same planar material, such that the strap 32 is a narrower extension of the cuff body 20 .
- the strap 32 and cuff body 20 have the same thickness.
- the strap 32 takes the form of a tongue that is suitably connected to the planar surface of the first region 36 of the cuff body 20 .
- the buckle 34 comprises an aperture 40 (as best shown in FIG.
- the width w of the strap 32 is preferably slightly less or equal to the width of the aperture 40 of the buckle 34 before the strap 32 is inserted through the aperture 40 of the buckle 34 .
- the strap 32 may be pulled through the aperture 40 (shown in FIG. 3 ) of the buckle 34 .
- the buckle 34 , aperture 40 , and strap 32 are sized in a manner, such that when the strap 32 is pulled through the aperture 40 , the outer surface of the strap 32 firmly engages the inner surface of the buckle 34 .
- the electrode lead 10 further comprises a locking feature closely associated with the strap 32 for interacting with the buckle 34 in a manner that prevents the strap 32 from being pulled back through the buckle 34 .
- the locking feature takes the form of at least one raised protuberance 42 a (only a single protuberance 42 a is illustrated) disposed on the planar surface of the strap 32 .
- the protuberance 42 a may be, e.g., a button 42 a - 1 ( FIG. 5 a ) or a dome 42 a - 2 ( FIG. 5 b ).
- the protuberance 42 a is positioned on the strap 32 , such that the strap 32 , with the protuberance 42 a , will pass all the way through the aperture 40 of the buckle 34 when the cuff body 20 a is placed around the nerve 26 .
- the protuberance 42 a may hinder the insertion of the strap 32 through the aperture 40 of the buckle 34 (as shown in FIGS. 6 a and 6 b ), due to the elastomeric nature of the buckle 34 and the protuberance 42 a , the protuberance 42 a can be pulled within the aperture 40 of the buckle 34 (as shown in FIGS. 7 a and 7 b ), and then out through the aperture 40 of the buckle 34 (as shown in FIGS. 8 a and 8 b ) in response to the application of a substantial amount of tensile force to end of the strap 32 in the direction 46 , e.g., by using a surgical tool, such as tweezers.
- a surgical tool such as tweezers.
- the combined height h 1 ( FIG. 6 b ) of the protuberance 42 a and strap 32 is preferably selected, such that the buckle 34 can stretch and expand enough to accommodate its passage through the aperture 40 of the buckle when a substantial tensile force is applied to the strap 32 using a surgical tool, while ensuring that the buckle 34 cannot distort enough to overcome the abutment force between the protuberance 42 a and the edge 44 of the buckle 34 after implantation of the cuff body 20 a around the nerve 26 .
- FIG. 6 b The combined height h 1 ( FIG. 6 b ) of the protuberance 42 a and strap 32 is preferably selected, such that the buckle 34 can stretch and expand enough to accommodate its passage through the aperture 40 of the buckle when a substantial tensile force is applied to the strap 32 using a surgical tool, while ensuring that the buckle 34 cannot distort enough to overcome the abutment force between the protuberance 42 a and the edge 44 of the buckle 34 after implantation of the cuff body 20 a around
- the combined height h 1 of the protuberance 42 a and strap 32 , in their relaxed state, is greater than the height h 2 of the aperture 40 of the buckle 34 , in its relaxed state, but less than twice the height h 2 of the aperture 40 of the buckle 34 , in its relaxed state.
- a cuff body 20 b is the same as the cuff body 20 a described above, but instead of a protuberance, the locking feature takes the form of a ring 42 b incorporated into the strap 32 .
- the ring 42 b in its relaxed state, may be a circular ring 42 b ( 1 ) ( FIG. 11 a ), although in other embodiments, the ring 42 b , in its relaxed state, may be an oval ring 42 b ( 2 ) ( FIG. 11 b ) or even a rectangular ring 42 b ( 3 ) ( FIG. 11 c ).
- the ring 42 b is positioned on the strap 32 , such that the strap 32 , along with the ring 42 b , will pass all the way through the aperture 40 of the buckle 34 when the cuff body 20 b is placed around the nerve 26 .
- the ring 42 b in its relaxed state, may hinder the insertion of the strap 32 through the aperture 40 of the buckle 34 (as shown in FIGS. 12 a and 12 b ), due to the elastomeric nature of the ring 42 b , the ring 42 b collapses inward and can be pulled within the aperture 40 of the buckle 34 , which may expand to accommodate the collapsed ring 42 b (as shown in FIGS. 13 a and 13 b ).
- the collapsed ring 42 b may then be passed through the aperture 40 of the buckle 34 (as shown in FIGS. 14 a and 14 b ) in response to the application of a substantial amount of tensile force to the end of the strap 32 in the direction 46 , e.g., by using a surgical tool, such as tweezers.
- the width w 1 of the ring 42 b in its relaxed state, is preferably selected, such that the ring 42 b can collapse inwardly enough to pass through the aperture 40 of the buckle 34 when a tensile force is applied to the strap 32 using a surgical tool.
- the width w 1 of the ring 42 b in its relaxed state, is greater than the width w 2 of the aperture 40 of the buckle 34 , in its relaxed state, but less than twice the width w 2 of the aperture 40 of the buckle 34 , in its relaxed state.
- a cuff body 20 c is the same as the cuff body 20 b described above, but instead of a ring, the locking feature takes the form of a wrinkle 42 c incorporated into the strap 32 .
- the wrinkle 42 c in its relaxed state, may be a folded region 42 c - 1 (FIG. 17 a ), although in other embodiments, the wrinkle 42 c , in its relaxed state, may be a curved region 42 c - 2 ( FIG. 17 b ).
- the wrinkle 42 c is positioned along the length of strap 32 , such that the strap 32 , along with the wrinkle 42 c , will pass all the way through the aperture 40 of the buckle 34 when the cuff body 20 c is placed around the nerve 26 .
- the wrinkle 42 c in its relaxed state, may hinder the insertion of the strap 32 through the aperture 40 of the buckle 34 (as shown in FIGS. 18 a and 18 b ), due to the elastomeric nature of the wrinkle 42 c , the wrinkle 42 c straightens and can be pulled within the aperture 40 of the buckle 34 (as shown in FIGS. 19 a and 19 b ), and then out through the aperture 40 of the buckle 34 (as shown in FIGS.
- the span of the height h 1 of the wrinkle 42 c in its relaxed state, is preferably selected, such that the wrinkle 42 c can straighten enough to pass through the aperture 40 of the buckle when a tensile force is applied to the strap 32 using a surgical tool, while ensuring that the buckle 34 cannot collapse inwardly enough to overcome the abutment force between the wrinkle 42 c and the edge 44 of the buckle 34 in response to tensile forces applied to the strap 32 by the swelling of the nerve 26 .
- the wrinkle 42 c in its relaxed state, spans a height h 1 that is greater than the height h 2 of the aperture 40 of the buckle 34 , in its relaxed state, but less than twice the height h 2 of the aperture 40 of the buckle 34 , in its relaxed state.
- self-expanding features can be incorporated into the cuff body 20 (e.g., cuff bodies 20 a , 20 b , or 20 c ) to expand and accommodate both a normal-sized nerve diameter and then later, after implantation of the electrode lead 10 , an increased nerve diameter due to swelling, thereby preventing nerve constriction due to the nerve swelling, as described in U.S. patent application Ser. No. ______, entitled “Self-Adjusting Features in a Cuff Electrode,” which is expressly incorporated herein by reference.
Abstract
A lead comprising a lead body, a lead connector terminal affixed to a proximal end of the lead body, and a cuff body affixed to a distal end of the lead body, an electrode contact affixed to the cuff body, and an electrical conductor between the connector terminal and electrode contact. The lead further comprises a strap extending from a first region of the cuff body, a buckle disposed on a second region of the cuff body, and a locking feature, e.g., protuberance, ring, or wrinkle, associated with the strap. The locking feature is configured for being pulled through the buckle to dispose the cuff body around a nerve in response to a tensile force applied to the strap. The locking feature is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the cuff body around the nerve.
Description
- The present application is a continuation of U.S. patent application Ser. No. 15/967,332, filed Apr. 30, 2018, which claims the benefit of U.S. Provisional Patent Application Ser. No. 62/500,080, filed May 2, 2017, and U.S. Provisional Patent Application Ser. No. 62/500,091, filed May 2, 2017, which are expressly incorporated herein by reference. This application is also related to U.S. patent application Ser. No. 15/967,468, filed on Apr. 30, 2018, which is expressly incorporated herein by reference.
- The present invention generally relates to implantable neurostimulation leads, and specifically relates to implantable nerve cuff electrodes that can be used to stimulate nerves to treat ailments, such as obstructive sleep apnea (OSA).
- Obstructive sleep apnea (OSA) is a common disorder in which the upper airway of a patient can become obstructed (apnea) or partially obstructed (hypopnea) during sleep. It is highly prevalent, affecting 5%-10% of the adult population in the United States, and has serious effects and comorbidities, such as daytime sleepiness, snoring, poor sleep quality, and an increased risk of cardiovascular disease and motor vehicle accidents. Conventional treatments of OSA include using continuous positive airway pressure (CPAP) techniques or performing upper airway surgery. However, due to discomfort, CPAP has a low adherence rate over time, thereby limiting its effectiveness. Alternatively, upper airway surgery is painful and requires a prolonged recovery period, and therefore is used as a last resort to the treatment of OSA, reserved for only extreme cases.
- In response to disadvantages of the conventional techniques for treating OSA, a new approach involves stimulating the hypoglossal nerve or its branches, which innervates the upper airway muscle, to increase the patency of the upper airway of the patient, thereby preventing or minimizing the onset of OSA. For example, one such neurostimulation system for treating OSA includes a neurostimulator device that stimulates one or more branches of the hypoglossal nerve via electrodes that are implanted at the hypoglossal nerve. Further details discussing such a neurostimulation system are described in U.S. Patent Publication No. 2016/0354608, which is expressly incorporated herein by reference.
- It is desirable that any electrode implanted in contact with a nerve, such as the hypoglossal nerve, continually remain in firm contact with such nerve to maximize the effectiveness of the stimulation regimen. However, certain regions of the patient, such as the neck region, are subject to various dynamic forces that may dislodge or otherwise cause an electrode to migrate from or otherwise temporarily move from its original or desired implantation site, which may have deleterious effect on the stimulation regimen, and thus, the treatment of the ailment, such as OSA.
- A reliable solution to this migration problem is to use a nerve cuff electrode device, which can be circumferentially placed around the nerve to deliver effective electrical stimulation to that nerve. This approach provides a more effective anchoring means that keeps the electrode in firm contact with the nerve to which it is attached even when the implantation site is subject to dynamic forces. For treating OSA, a nerve cuff can be wrapped around the hypoglossal nerve trunk or its branch that innervates the muscle that protrudes the tongue.
- A conventional approach to securing a nerve cuff electrode to a nerve involves placing the cuff, which is generally C-shaped, around the nerve and tightly closing and sealing the cuff by tying sutures at two edges or flaps of the cuff to fully encircle the nerve. However, using sutures to secure the nerve cuff electrode has several disadvantages. For example, braided suture material easily attracts and retains contaminants, connective tissue can grow on the sutures making removal of the cuff difficult, and sutures tend to breakdown when exposed to a fluid environment, thereby resulting in failure of the sutures and potentially allowing the cuff to open.
- There, thus, remains a need for securing a nerve cuff electrode to a nerve.
- In accordance with present invention, an electrode lead comprises an elongated lead body, at least one lead connector terminal affixed to the proximal end of the lead body, and a biologically compatible, elastic, electrically insulative cuff body affixed to the distal end of the lead body, and at least one electrical conductor extending through the lead body between the connector terminal(s) and the electrode contact(s). The cuff body is configured for being circumferentially disposed around a nerve, and has opposing first and second regions. The cuff body may be composed of, e.g., silicone. The cuff body may be configured and sized for being placed around on a human hypoglossal nerve trunk or its branch nerve. The cuff body may be configured for expanding and accommodating both a normal-sized nerve diameter and then later, after implantation of the electrode lead, an increased nerve diameter due to swelling, thereby preventing nerve constriction due to the nerve swelling. In one embodiment, the electrode contact(s) is configured for being on an inner surface of the cuff body when secured around the nerve. The electrode lead further comprises a strap extending from the first region of the cuff body, and a buckle disposed on the second region of the cuff body. The strap may have, e.g., a thickness less than 1 mm.
- In accordance with a first aspect of the present invention, the electrode lead comprises at least one raised protuberance (e.g., a button or a dome) disposed on a planar surface of the strap. The strap with the raised protuberance(s) is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap, and one of the raised protuberance(s) is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the cuff body around the nerve. In another embodiment, the one raised protuberance and the strap, in their relaxed state, have a combined first height, and the aperture of the buckle, in its relaxed state, has a second height less than the first height. In still another embodiment, the first height is less than twice the second height.
- In accordance with a second aspect of the present invention, the electrode lead comprises a ring incorporated into the strap. The strap with the ring is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap, and the ring is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the cuff body around the nerve. In one embodiment, the ring, in its relaxed state, has a first width, and the aperture of the buckle, in its relaxed state, has a second width less than the first width. In still another embodiment, the first width is less than twice the second width. The ring, in its relaxed state may be, e.g., circular, oval, or rectangular.
- In accordance with a third aspect of the present invention, the electrode lead comprises at least one wrinkle (e.g., a folded region or a curved region) incorporated into the strap. The strap with the wrinkle(s) is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap, and one of the wrinkle(s) is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the tightened cuff body around the nerve. In one embodiment, the one wrinkle, in its relaxed state, spans a first height, and the aperture of the buckle, in its relaxed state, has a second height less than the first height. In still another embodiment, the first height is less than twice the second height.
- Other and further aspects and features of the invention will be evident from reading the following detailed description of the preferred embodiments, which are intended to illustrate, not limit, the invention.
- The drawings illustrate the design and utility of preferred embodiments of the present invention, in which similar elements are referred to by common reference numerals. In order to better appreciate how the above-recited and other advantages and objects of the present inventions are obtained, a more particular description of the present inventions briefly described above will be rendered by reference to specific embodiments thereof, which are illustrated in the accompanying drawings. Understanding that these drawings depict only typical embodiments of the invention and are not therefore to be considered limiting of its scope, the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
-
FIG. 1 is a perspective view of an electrode lead constructed in accordance with one embodiment of the present inventions; -
FIG. 2 is a plan view of a cuff electrode of the electrode lead ofFIG. 1 , which can be rolled up and circumferentially disposed around a nerve; -
FIG. 3 is an end view of the cuff electrode ofFIG. 2 ; -
FIG. 4 is a perspective view of the cuff electrode ofFIG. 2 , particularly showing a protuberance used in a strap and buckle arrangement for securing the cuff electrode to the nerve; -
FIG. 5a is a side view of one embodiment of the protuberance ofFIG. 4 in the form of a button; -
FIG. 5b is a side view of another embodiment of the protuberance ofFIG. 4 in the form of a dome; -
FIGS. 6a and 6b are respective top and side views illustrating the protuberance prior to pulling the strap through the buckle; -
FIGS. 7a and 7b are respective top and side views illustrating the protuberance pulled into the buckle by pulling the strap; -
FIGS. 8a and 8b are respective top and side views illustrating the protuberance pulled out of the buckle by pulling the strap; -
FIGS. 9a and 9b are respective top and side views illustrating the protuberance engaging the edge of the buckle in a locked position by releasing tension on the strap; -
FIG. 10 is a perspective view of the cuff electrode ofFIG. 2 , particularly showing a ring used in a strap and buckle arrangement for securing the cuff electrode to the nerve; -
FIG. 11a is a top view of one embodiment of the ring ofFIG. 10 in the form of a circular ring; -
FIG. 11b is a top view of another embodiment of the ring ofFIG. 10 in the form of an oval ring; -
FIG. 11c is a top view of still another embodiment of the ring ofFIG. 10 in the form of a rectangular ring; -
FIGS. 12a and 12b are respective top and side views illustrating the ring prior to pulling the strap through the buckle; -
FIGS. 13a and 13b are respective top and side views illustrating the ring pulled into the buckle by pulling the strap; -
FIGS. 14a and 14b are respective top and side views illustrating the ring pulled out of the buckle by pulling the strap; -
FIGS. 15a and 15b are respective top and side views illustrating the ring engaging the edge of the buckle in a locked position by releasing tension on the strap; -
FIG. 16 is a perspective view of the cuff electrode ofFIG. 2 , particularly showing a wrinkle used in a strap and buckle arrangement for securing the cuff electrode to the nerve; -
FIG. 17a is a side view of one embodiment of the wrinkle ofFIG. 16 in the form of a folded region; -
FIG. 17b is a side view of another embodiment of the wrinkle ofFIG. 16 in the form of a curved region; -
FIGS. 18a and 18b are respective top and side views illustrating the wrinkle prior to pulling the strap through the buckle; -
FIGS. 19a and 19b are respective top and side views illustrating the wrinkle pulled into the buckle by pulling the strap; -
FIGS. 20a and 20b are respective top and side views illustrating the wrinkle pulled out of the buckle by pulling the strap; and -
FIGS. 21a and 21b are respective top and side views illustrating the wrinkle engaging the edge of the buckle in a locked position by releasing tension on the strap. - Referring to
FIGS. 1-3 , anelectrode lead 10 constructed in accordance with one embodiment of the present invention will now be described. Although theelectrode lead 10 lends itself well to be used in the treatment of OSA by stimulating the hypoglossal nerve, theelectrode lead 10 may be used for any medical treatment where it is desired to stimulate a nerve. - The
electrode lead 10 generally comprises anelongated lead body 12 having aproximal end 14 and adistal end 16, at least one lead connector terminal 18 (two shown) affixed to theproximal end 14 of thelead body 12, acuff body 20 affixed to thedistal end 16 of thelead body 12, at least one electrode contact 22 (three shown inFIG. 2 ) disposed on thecuff body 20, and at least one electrical conductor 24 (two shown) extending through the lead body between thelead connector terminals 18 and theelectrode contacts 22. As shown, thecuff body 20 can be circumferentially disposed around tissue, e.g., anerve 26, such that theelectrode contacts 22 are disposed on an inner surface of thecuff body 20 in contact with thenerve 26. - In the illustrated embodiment shown in
FIGS. 2 and 3 , theelectrode contacts 22 may be used to form a guarded tripolar electrode arrangement (e.g., anode-cathode-anode) for purposes of stimulating thenerve 26. Two of the electrode contacts 22 (the anodes) are ganged together and coupled to one of thelead connector terminals 18 via anelectrical conductor 24, and the remaining electrode contact 22 (the cathode) is coupled to the otherlead connector terminal 18 via the otherelectrical conductor 24. It should be appreciated that, alternatively, the number ofelectrode contacts 22,lead connector terminals 18, andelectrical conductors 24 can be identical, such thatelectrode contacts 22 may be energized independently of each other. - To this end, the
lead connector terminals 18 of theproximal end 14 of thelead body 12 can be inserted into aconnector block 30 of aneurostimulation device 28, which supplies electrical pulses to one or more of theelectrode contacts 22 in accordance with a stimulation regimen. Recording electrodes (not shown) can also be connected to theneurostimulation device 28 to provide sensed physiological signals to theneurostimulation device 28. In an alternative embodiment, one or more of theelectrode contacts 22 of theelectrode lead 10 can serve as a recording electrode. - The
lead body 12 andcuff body 20 may be composed of an elastic, electrically insulative, biocompatible, material, such as, e.g., medical-grade silicone, polyurethane, etc. Thelead connector terminals 18 may be composed of a suitable electrically conductive material, such as, e.g., stainless steel, and theelectrode contacts 22 may be composed of a suitable electrically conductive and biocompatible material, such as gold, or 90/10 or 80/20 Platinum-Iridium alloy. Theelectrical conductors 24 may likewise be composed of a suitable electrically conductive and biocompatible material, such as MP35N, MP35N with silver core, stainless steel, or tantalum. Thecuff body 20 is relatively thin, e.g., and may have a thickness less than 1 mm, and may often be less than 0.5 mm, so that thecuff body 20 may be easily disposed around in conformance with thenerve 26. Thecuff body 20 may take the form of a planar sheet (as best shown inFIG. 2 ) that can be rolled up on itself to be circumferentially disposed around the nerve 26 (as best shown inFIG. 1 ). - The
electrode lead 10 includes locking features that allow thecuff body 20 to be secured around thenerve 26 without the use of sutures and in a manner that minimizes the chance that thecuff body 20 can be dislodged from thenerve 26 after implantation of the cuff around the nerve. - In particular, the
cuff body 20 may comprise astrap 32 extending from afirst region 36 of thecuff body 20, and abuckle 34 disposed on the surface of asecond region 38 of thecuff body 20. In the illustrated embodiment, thestrap 32 andcuff body 20 are unitary in nature and may be formed of the same planar material, such that thestrap 32 is a narrower extension of thecuff body 20. Thus, in the embodiment shown, thestrap 32 andcuff body 20 have the same thickness. In the illustrated embodiment, thestrap 32 takes the form of a tongue that is suitably connected to the planar surface of thefirst region 36 of thecuff body 20. Thebuckle 34 comprises an aperture 40 (as best shown inFIG. 3 ) through which thestrap 32 can be inserted to allow thecuff body 20 to be conveniently secured around thenerve 26. The width w of thestrap 32 is preferably slightly less or equal to the width of theaperture 40 of thebuckle 34 before thestrap 32 is inserted through theaperture 40 of thebuckle 34. As best shown inFIG. 1 , thestrap 32 may be pulled through the aperture 40 (shown inFIG. 3 ) of thebuckle 34. Thebuckle 34,aperture 40, andstrap 32 are sized in a manner, such that when thestrap 32 is pulled through theaperture 40, the outer surface of thestrap 32 firmly engages the inner surface of thebuckle 34. - The
electrode lead 10 further comprises a locking feature closely associated with thestrap 32 for interacting with thebuckle 34 in a manner that prevents thestrap 32 from being pulled back through thebuckle 34. - In one embodiment of a
cuff body 20 a illustrated inFIGS. 4-9 , the locking feature takes the form of at least one raisedprotuberance 42 a (only asingle protuberance 42 a is illustrated) disposed on the planar surface of thestrap 32. Theprotuberance 42 a may be, e.g., a button 42 a-1 (FIG. 5a ) or a dome 42 a-2 (FIG. 5b ). Theprotuberance 42 a is positioned on thestrap 32, such that thestrap 32, with theprotuberance 42 a, will pass all the way through theaperture 40 of thebuckle 34 when thecuff body 20 a is placed around thenerve 26. - Although the
protuberance 42 a may hinder the insertion of thestrap 32 through theaperture 40 of the buckle 34 (as shown inFIGS. 6a and 6b ), due to the elastomeric nature of thebuckle 34 and theprotuberance 42 a, theprotuberance 42 a can be pulled within theaperture 40 of the buckle 34 (as shown inFIGS. 7a and 7b ), and then out through theaperture 40 of the buckle 34 (as shown inFIGS. 8a and 8b ) in response to the application of a substantial amount of tensile force to end of thestrap 32 in thedirection 46, e.g., by using a surgical tool, such as tweezers. When the tensile force is released from thestrap 32, the spring force built up in thestrap 32 by the previous application of the tensile force in thedirection 46 causes theprotuberance 42 a to retract back towards thebuckle 34 in thedirection 48, causing theprotuberance 42 a to abut theedge 44 of thebuckle 34, thereby securing and locking thecuff body 20 a around the nerve 26 (as shown inFIGS. 9a and 9b ). - The combined height h1 (
FIG. 6b ) of theprotuberance 42 a andstrap 32 is preferably selected, such that thebuckle 34 can stretch and expand enough to accommodate its passage through theaperture 40 of the buckle when a substantial tensile force is applied to thestrap 32 using a surgical tool, while ensuring that thebuckle 34 cannot distort enough to overcome the abutment force between theprotuberance 42 a and theedge 44 of thebuckle 34 after implantation of thecuff body 20 a around thenerve 26. In the illustrated embodiment shown inFIG. 6b , the combined height h1 of theprotuberance 42 a andstrap 32, in their relaxed state, is greater than the height h2 of theaperture 40 of thebuckle 34, in its relaxed state, but less than twice the height h2 of theaperture 40 of thebuckle 34, in its relaxed state. - Referring now to
FIGS. 10-15 , another embodiment of acuff body 20 b is the same as thecuff body 20 a described above, but instead of a protuberance, the locking feature takes the form of aring 42 b incorporated into thestrap 32. In the illustrated embodiment, thering 42 b, in its relaxed state, may be acircular ring 42 b(1) (FIG. 11a ), although in other embodiments, thering 42 b, in its relaxed state, may be anoval ring 42 b(2) (FIG. 11b ) or even arectangular ring 42 b(3) (FIG. 11c ). - The
ring 42 b is positioned on thestrap 32, such that thestrap 32, along with thering 42 b, will pass all the way through theaperture 40 of thebuckle 34 when thecuff body 20 b is placed around thenerve 26. Although thering 42 b, in its relaxed state, may hinder the insertion of thestrap 32 through theaperture 40 of the buckle 34 (as shown inFIGS. 12a and 12b ), due to the elastomeric nature of thering 42 b, thering 42 b collapses inward and can be pulled within theaperture 40 of thebuckle 34, which may expand to accommodate thecollapsed ring 42 b (as shown inFIGS. 13a and 13b ). Thecollapsed ring 42 b may then be passed through theaperture 40 of the buckle 34 (as shown inFIGS. 14a and 14b ) in response to the application of a substantial amount of tensile force to the end of thestrap 32 in thedirection 46, e.g., by using a surgical tool, such as tweezers. When the tensile force is released from thestrap 32, the spring force built up in thestrap 32 by the previous application of the tensile force in thedirection 46 causes thering 42 b to expand outward to its relaxed state and retract back towards thebuckle 34 in thedirection 48, causing it to abut theedge 44 of thebuckle 34, thereby securing and locking thecuff body 20 b around the nerve 26 (as shown inFIGS. 15a and 15b ). - The width w1 of the
ring 42 b, in its relaxed state, is preferably selected, such that thering 42 b can collapse inwardly enough to pass through theaperture 40 of thebuckle 34 when a tensile force is applied to thestrap 32 using a surgical tool. In the illustrated embodiment shown inFIG. 12a , the width w1 of thering 42 b, in its relaxed state, is greater than the width w2 of theaperture 40 of thebuckle 34, in its relaxed state, but less than twice the width w2 of theaperture 40 of thebuckle 34, in its relaxed state. - Referring now to
FIGS. 16-21 , still another embodiment of acuff body 20 c is the same as thecuff body 20 b described above, but instead of a ring, the locking feature takes the form of awrinkle 42 c incorporated into thestrap 32. In the illustrated embodiment, thewrinkle 42 c, in its relaxed state, may be a foldedregion 42 c-1 (FIG. 17 a), although in other embodiments, thewrinkle 42 c, in its relaxed state, may be acurved region 42 c-2 (FIG. 17b ). - The
wrinkle 42 c is positioned along the length ofstrap 32, such that thestrap 32, along with thewrinkle 42 c, will pass all the way through theaperture 40 of thebuckle 34 when thecuff body 20 c is placed around thenerve 26. Although thewrinkle 42 c, in its relaxed state, may hinder the insertion of thestrap 32 through theaperture 40 of the buckle 34 (as shown inFIGS. 18a and 18b ), due to the elastomeric nature of thewrinkle 42 c, thewrinkle 42 c straightens and can be pulled within theaperture 40 of the buckle 34 (as shown inFIGS. 19a and 19b ), and then out through theaperture 40 of the buckle 34 (as shown inFIGS. 20a and 20b ) in response to the application of a substantial amount of tensile force to thestrap 32 in thedirection 46, e.g., by using a surgical tool, such as tweezers. When the tensile force is released from thestrap 32, the spring force built up in thestrap 32 by the previous application of the tensile force in thedirection 46 causes thewrinkle 42 c to bend back to its relaxed state and retract back towards thebuckle 34 in thedirection 48, causing it to abut theedge 44 of thebuckle 34, thereby securing and locking thecuff body 20 c around the nerve 26 (as shown inFIGS. 21a and 21b ). - The span of the height h1 of the
wrinkle 42 c, in its relaxed state, is preferably selected, such that thewrinkle 42 c can straighten enough to pass through theaperture 40 of the buckle when a tensile force is applied to thestrap 32 using a surgical tool, while ensuring that thebuckle 34 cannot collapse inwardly enough to overcome the abutment force between thewrinkle 42 c and theedge 44 of thebuckle 34 in response to tensile forces applied to thestrap 32 by the swelling of thenerve 26. In the illustrated embodiment, thewrinkle 42 c, in its relaxed state, spans a height h1 that is greater than the height h2 of theaperture 40 of thebuckle 34, in its relaxed state, but less than twice the height h2 of theaperture 40 of thebuckle 34, in its relaxed state. - In optional embodiments, self-expanding features can be incorporated into the cuff body 20 (e.g.,
cuff bodies electrode lead 10, an increased nerve diameter due to swelling, thereby preventing nerve constriction due to the nerve swelling, as described in U.S. patent application Ser. No. ______, entitled “Self-Adjusting Features in a Cuff Electrode,” which is expressly incorporated herein by reference. - Although particular embodiments of the present inventions have been shown and described, it will be understood that it is not intended to limit the present inventions to the preferred embodiments, and it will be obvious to those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the present inventions. Thus, the present inventions are intended to cover alternatives, modifications, and equivalents, which may be included within the spirit and scope of the present inventions as defined by the claims.
Claims (1)
1. An electrode lead, comprising:
an elongated lead body having a proximal end and a distal end;
at least one lead connector terminal affixed to the proximal end of the lead body;
a biologically compatible, elastic, electrically insulative cuff body affixed to the distal end of the lead body, the cuff body configured for being circumferentially disposed around a nerve, the cuff body having opposing first and second regions;
at least one electrode contact affixed to the cuff body;
at least one electrical conductor extending through the lead body between the at least one lead connector terminal and the at least one electrode contact;
a strap extending from the first region of the cuff body;
a buckle disposed on the second region of the cuff body; and
at least one raised protuberance disposed on a planar surface of the strap;
wherein the strap with the at least one raised protuberance is configured for being pulled through an aperture of the buckle to dispose the cuff body around the nerve in response to a tensile force applied to the strap; and
wherein one of the at least one raised protuberance is configured for abutting an edge of the buckle in response to a release of the tensile force to secure the cuff body around the nerve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/308,350 US20210268270A1 (en) | 2017-05-02 | 2021-05-05 | Nerve cuff electrode locking mechanism |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762500080P | 2017-05-02 | 2017-05-02 | |
US201762500091P | 2017-05-02 | 2017-05-02 | |
US15/967,332 US20180318577A1 (en) | 2017-05-02 | 2018-04-30 | Nerve cuff electrode locking mechanism |
US17/308,350 US20210268270A1 (en) | 2017-05-02 | 2021-05-05 | Nerve cuff electrode locking mechanism |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/967,332 Continuation US20180318577A1 (en) | 2017-05-02 | 2018-04-30 | Nerve cuff electrode locking mechanism |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210268270A1 true US20210268270A1 (en) | 2021-09-02 |
Family
ID=64013519
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/967,332 Abandoned US20180318577A1 (en) | 2017-05-02 | 2018-04-30 | Nerve cuff electrode locking mechanism |
US15/967,468 Active 2038-11-04 US10981000B2 (en) | 2017-05-02 | 2018-04-30 | Self-expanding nerve cuff electrode |
US17/206,087 Active 2038-07-08 US11844941B2 (en) | 2017-05-02 | 2021-03-18 | Self-expanding nerve cuff electrode |
US17/308,350 Pending US20210268270A1 (en) | 2017-05-02 | 2021-05-05 | Nerve cuff electrode locking mechanism |
US18/508,061 Pending US20240082572A1 (en) | 2017-05-02 | 2023-11-13 | Self-expanding nerve cuff electrode |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/967,332 Abandoned US20180318577A1 (en) | 2017-05-02 | 2018-04-30 | Nerve cuff electrode locking mechanism |
US15/967,468 Active 2038-11-04 US10981000B2 (en) | 2017-05-02 | 2018-04-30 | Self-expanding nerve cuff electrode |
US17/206,087 Active 2038-07-08 US11844941B2 (en) | 2017-05-02 | 2021-03-18 | Self-expanding nerve cuff electrode |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/508,061 Pending US20240082572A1 (en) | 2017-05-02 | 2023-11-13 | Self-expanding nerve cuff electrode |
Country Status (1)
Country | Link |
---|---|
US (5) | US20180318577A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8934992B2 (en) | 2011-09-01 | 2015-01-13 | Inspire Medical Systems, Inc. | Nerve cuff |
EP3411116B1 (en) | 2016-02-05 | 2020-01-22 | Boston Scientific Neuromodulation Corporation | Implantable optical stimulation lead |
EP3664889B1 (en) | 2017-08-11 | 2024-02-21 | Inspire Medical Systems, Inc. | Cuff electrode |
EP3768372A1 (en) | 2018-03-23 | 2021-01-27 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making and using |
WO2019183054A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
WO2020102039A1 (en) | 2018-11-16 | 2020-05-22 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making |
US11273305B2 (en) * | 2020-01-24 | 2022-03-15 | Medtronic Xomed, Inc. | Medical lead for treating obstructive sleep apnea (OSA) with electrical stimulation |
US20220062629A1 (en) | 2020-09-02 | 2022-03-03 | The Alfred E. Mann Foundation For Scientific Research | Electrode leads having multi-application nerve cuffs and associated systems and methods |
WO2022051295A1 (en) | 2020-09-04 | 2022-03-10 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling and methods of making and using |
JP2024503382A (en) * | 2021-01-19 | 2024-01-25 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Electrical stimulation cuff devices and systems with directional electrode configurations |
AU2022249112A1 (en) | 2021-03-30 | 2023-10-12 | The Alfred E. Mann Foundation For Scientific Research | Electrode leads having nerve cuffs and associated systems |
US11833348B2 (en) | 2021-07-09 | 2023-12-05 | The Alfred E. Mann Foundation For Scientific Research | Electrode leads having multi-application helical nerve cuffs and associated systems and methods |
US20230241394A1 (en) | 2022-02-01 | 2023-08-03 | The Alfred E. Mann Foundation For Scientific Research | Electrode leads having nerve contact elements with coil contacts and associated systems and methods |
WO2024010990A1 (en) | 2022-07-05 | 2024-01-11 | The Alfred E. Mann Foundation For Scientific Research | Tissue stimulation apparatus and methods of making the same |
WO2024073257A1 (en) | 2022-09-29 | 2024-04-04 | The Alfred E. Mann Foundation For Scientific Research | Electrode leads having nerve cuffs and associated systems and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8116882B2 (en) * | 2008-02-15 | 2012-02-14 | Angeltear Solutions Inc. | Adjustable tissue or nerve cuff and method of use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940065A (en) * | 1989-01-23 | 1990-07-10 | Regents Of The University Of California | Surgically implantable peripheral nerve electrode |
US5400784A (en) * | 1993-10-15 | 1995-03-28 | Case Western Reserve University | Slowly penetrating inter-fascicular nerve cuff electrode and method of using |
US5487756A (en) * | 1994-12-23 | 1996-01-30 | Simon Fraser University | Implantable cuff having improved closure |
US6600956B2 (en) * | 2001-08-21 | 2003-07-29 | Cyberonics, Inc. | Circumneural electrode assembly |
US9186511B2 (en) * | 2006-10-13 | 2015-11-17 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
EP3527255B1 (en) | 2006-10-13 | 2020-08-05 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices and systems |
US8340785B2 (en) | 2008-05-02 | 2012-12-25 | Medtronic, Inc. | Self expanding electrode cuff |
EP2310084B1 (en) * | 2008-05-02 | 2016-03-23 | Medtronic, Inc. | Electrode lead system |
US8934992B2 (en) | 2011-09-01 | 2015-01-13 | Inspire Medical Systems, Inc. | Nerve cuff |
US11833356B2 (en) * | 2016-02-17 | 2023-12-05 | Galvani Bioelectronics Limited | Extraneural cuff with flexible interconnects for stimulation and recording |
-
2018
- 2018-04-30 US US15/967,332 patent/US20180318577A1/en not_active Abandoned
- 2018-04-30 US US15/967,468 patent/US10981000B2/en active Active
-
2021
- 2021-03-18 US US17/206,087 patent/US11844941B2/en active Active
- 2021-05-05 US US17/308,350 patent/US20210268270A1/en active Pending
-
2023
- 2023-11-13 US US18/508,061 patent/US20240082572A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8116882B2 (en) * | 2008-02-15 | 2012-02-14 | Angeltear Solutions Inc. | Adjustable tissue or nerve cuff and method of use |
Also Published As
Publication number | Publication date |
---|---|
US20240082572A1 (en) | 2024-03-14 |
US20180318577A1 (en) | 2018-11-08 |
US11844941B2 (en) | 2023-12-19 |
US20180318578A1 (en) | 2018-11-08 |
US20210205614A1 (en) | 2021-07-08 |
US10981000B2 (en) | 2021-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210268270A1 (en) | Nerve cuff electrode locking mechanism | |
US8340785B2 (en) | Self expanding electrode cuff | |
US10384056B2 (en) | Nerve cuff for implantable electrode | |
JP5575113B2 (en) | Self-expanding electrode cuff | |
US11779759B2 (en) | Stimulator systems and methods for selectively recruiting fascicles in hypoglossal nerve trunk | |
US6600956B2 (en) | Circumneural electrode assembly | |
US7363089B2 (en) | Method of use of implantable percutaneous stimulation lead | |
US7904179B2 (en) | Implantable medical device system with fixation member | |
US8494657B2 (en) | Resorbable anchor arrangements for implantable devices and methods of making and using | |
JP2009532185A (en) | Implantable extravascular electrical stimulation system with elastic cuff | |
EP0190195A1 (en) | Process and apparatus for diaphragmic stimulation. | |
KR102318302B1 (en) | Nerve cuff electrode for neuromodulation in large human nerve trunks | |
DeGiorgio et al. | Surgical anatomy, implantation technique, and operative complications | |
WO2011137042A1 (en) | Spinal cord stimulator lead anchor | |
US20130123866A1 (en) | Neurostimulation system with lead fastener and methods of making and using | |
US20160038736A1 (en) | Electro catheter for neurostimulation | |
WO2024073257A1 (en) | Electrode leads having nerve cuffs and associated systems and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |